← FDA Drug Approvals (Drugs@FDA)

ELDEPRYL

NDA · New Drug Application · Sponsor: QUAGEN · Approved 1996-05-15

Drug application

FDA Application #

NDA020647

Application type

New Drug Application

Brand name

ELDEPRYL

Generic name

Selegiline Hydrochloride

Active ingredients

SELEGILINE HYDROCHLORIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

QUAGEN

First approval

1996-05-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown